Cooper Companies Inc (COO) Shares Sold by Carillon Tower Advisers Inc.

Carillon Tower Advisers Inc. reduced its holdings in shares of Cooper Companies Inc (NYSE:COO) by 22.6% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 11,300 shares of the medical device company’s stock after selling 3,300 shares during the quarter. Carillon Tower Advisers Inc.’s holdings in Cooper Companies were worth $3,346,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also made changes to their positions in the company. Essex Savings Bank bought a new position in shares of Cooper Companies during the fourth quarter valued at $25,000. Certified Advisory Corp bought a new position in shares of Cooper Companies during the fourth quarter valued at $25,000. Executive Wealth Management LLC bought a new position in shares of Cooper Companies during the fourth quarter valued at $34,000. Financial Gravity Companies Inc. bought a new position in shares of Cooper Companies during the fourth quarter valued at $46,000. Finally, Quadrant Capital Group LLC lifted its holdings in shares of Cooper Companies by 827.8% during the first quarter. Quadrant Capital Group LLC now owns 167 shares of the medical device company’s stock valued at $47,000 after purchasing an additional 149 shares in the last quarter.

COO stock opened at $290.76 on Thursday. Cooper Companies Inc has a fifty-two week low of $221.50 and a fifty-two week high of $302.36. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.75 and a current ratio of 1.27. The stock has a market capitalization of $14.16 billion, a price-to-earnings ratio of 25.28, a PEG ratio of 2.22 and a beta of 0.85.

Cooper Companies (NYSE:COO) last posted its earnings results on Tuesday, March 5th. The medical device company reported $2.88 earnings per share for the quarter, beating analysts’ consensus estimates of $2.50 by $0.38. Cooper Companies had a return on equity of 17.56% and a net margin of 14.22%. The company had revenue of $628.10 million for the quarter, compared to the consensus estimate of $618.50 million. On average, equities analysts predict that Cooper Companies Inc will post 12.01 earnings per share for the current year.

A number of research analysts have weighed in on the company. Zacks Investment Research downgraded Cooper Companies from a “buy” rating to a “hold” rating in a report on Tuesday, May 7th. Jefferies Financial Group increased their target price on Cooper Companies to $330.00 and gave the company a “buy” rating in a report on Wednesday, March 6th. Wells Fargo & Co increased their target price on Cooper Companies from $305.00 to $325.00 and gave the company an “outperform” rating in a report on Wednesday, March 6th. Stephens increased their target price on Cooper Companies from $305.00 to $320.00 and gave the company an “overweight” rating in a report on Wednesday, March 6th. Finally, Raymond James increased their target price on Cooper Companies from $300.00 to $325.00 and gave the company an “outperform” rating in a report on Wednesday, March 6th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and nine have issued a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $307.90.

In other Cooper Companies news, insider Robert D. Auerbach sold 5,326 shares of the company’s stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $300.00, for a total value of $1,597,800.00. Following the completion of the sale, the insider now owns 4,954 shares in the company, valued at $1,486,200. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, SVP Agostino Ricupati sold 2,400 shares of the company’s stock in a transaction dated Friday, March 29th. The stock was sold at an average price of $296.13, for a total value of $710,712.00. Following the completion of the sale, the senior vice president now owns 400 shares of the company’s stock, valued at approximately $118,452. The disclosure for this sale can be found here. In the last three months, insiders sold 87,030 shares of company stock worth $25,461,465. 1.70% of the stock is owned by corporate insiders.

WARNING: “Cooper Companies Inc (COO) Shares Sold by Carillon Tower Advisers Inc.” was published by WKRB News and is owned by of WKRB News. If you are viewing this news story on another domain, it was illegally stolen and republished in violation of US and international copyright & trademark laws. The original version of this news story can be accessed at https://www.wkrb13.com/2019/05/16/cooper-companies-inc-coo-shares-sold-by-carillon-tower-advisers-inc.html.

Cooper Companies Company Profile

The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.

See Also: Do Tariffs Work?

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies Inc (NYSE:COO).

Institutional Ownership by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.